3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
30
Neoplasm Metastasis
3
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Metastatic Castration-resistant Prostate Cancer
2
Urologic Diseases
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Radiation Injuries
1
Prostatic Diseases
1
Prostate Cancer Metastatic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligometastatic Prostate Cancer
1
Neoplasm Recurrence, Local
1
Metastatic Hormone Sensitive Prostate Cancer
1
Metastatic Castrate-sensitive Prostate Cancer
1
Hormone Sensitive Prostate Cancer
1
Genital Neoplasms, Male
1
Gastrointestinal Diseases
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Cisplatin
2
tislelizumab
1
radium Ra 223 dichloride
1
peposertib
1
encorafenib
1
cabozantinib
1
binimetinib
1
avelumab
1
alovudine
1
X-Rays
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Propranolol
1
Platinum Compounds
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Laparoscopy
1
Ipilimumab
1
Gemcitabine
1
DNA Mismatch Repair
1
Conversion to Open Surgery
1
Carboplatin
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphatic Metastasis
×
Androgen Antagonists
×
90 days
×
Clear all
No trials found.